Join
Integra LifeSciences Holdings Corporation logo

IART

NASDAQ

Integra LifeSciences Holdings Corporation

SectorHealth CareIndustryMedical/Dental Instruments
$17.14+0.15 (+0.88%)
News25/Ratings12

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Price$17.14+7.28 (+73.71%)
2026-03-052026-06-08
News · 26 weeks47-56%
2025-12-14: 02025-12-21: 02025-12-28: 02026-01-04: 22026-01-11: 02026-01-18: 02026-01-25: 02026-02-01: 22026-02-08: 12026-02-15: 12026-02-22: 42026-03-01: 02026-03-08: 82026-03-15: 12026-03-22: 12026-03-29: 02026-04-05: 22026-04-12: 22026-04-19: 12026-04-26: 02026-05-03: 92026-05-10: 62026-05-17: 12026-05-24: 22026-05-31: 42026-06-07: 0
2025-12-142026-06-07
Mix3790d
  • Insider16(43%)
  • SEC Filings8(22%)
  • Other7(19%)
  • Earnings3(8%)
  • Analyst2(5%)
  • Leadership1(3%)

Latest news

25 items

IART FAQ

6 questions
  • What does Integra LifeSciences Holdings Corporation do?
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps...
  • Where does IART stock trade?
    Integra LifeSciences Holdings Corporation (IART) is listed on NASDAQ.
  • What sector and industry is IART in?
    Integra LifeSciences Holdings Corporation operates in the Health Care sector, Medical/Dental Instruments industry.
  • What are analysts saying about IART?
    Integra LifeSciences Holdings Corporation has had 8 recent analyst actions on file. The most recent action was from Citigroup: Neutral with a $1600.00 price target on 2026-05-28. Recent price targets range from $1600.00 to $2300.00.
  • What companies are similar to IART?
    Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare IART side-by-side with any of them on Quantisnow.
  • How can I track IART on Quantisnow?
    Quantisnow aggregates Integra LifeSciences Holdings Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IART to receive live email and push alerts on every new disclosure.